To determine whether Treg depletion unleashes an anti-tumour immune response to ApcΔISC, through induction of IFNγ-producing, Granzyme B + T cells capable of killing ISCs7,8 we administered CD4 or CD8 depleting antibodies. The gene discussed is CD8A; the disease is neoplasm.